Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Drug Delivery Market
3.2. Development Of Drug Delivery System
3.3. Market Definition
3.4. Key Drivers
3.4.1. Growing Prevalence Of Respiratory Disease
3.4.2. Advancements In Technology
3.4.3. Rising Geriatric Population
3.5. Key Restraints
3.5.1. Stringent Regulation And Patent Expiry
3.5.2. Increasing Drug Recalls And Drug Failures
3.5.3. Side Effects And Risk Associated With The Drugs

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Impact Of Covid-19 On Pulmonary Drug Delivery Market
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Application
5.1. Asthma
5.2. Chronic Obstructive Pulmonary Disease
5.3. Allergic Rhinitis
5.4. Cystic Fibrosis
5.5. Other Applications

6. Market By Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. E-Commerce

7. Market By End-User
7.1. Hospitals & Clinics
7.2. Homecare

8. Market By Product
8.1. Metered Dose Inhalers
8.2. Dry Powder Inhalers
8.3. Nebulizer
8.3.1. Pneumatic Nebulizer
8.3.2. Mesh Nebulizer
8.3.3. Ultrasonic Nebulizer
8.4. Accessories

9. Geographical Analysis
9.1. North America
9.1.1. The United States
9.1.2. Canada

10. Company Profiles
10.1. 3M Company
10.2. Actelion Pharmaceuticals Ltd
10.3. Aerogen
10.4. Agilent Technologies Inc
10.5. Astrazeneca Plc
10.6. Boehringer Ingelheim Gmbh
10.7. Clement Clarke International
10.8. Gf Health Products Inc
10.9. Glaxosmithkline Plc
10.10. Koninklijke Philips Nv
10.11. Merck & Co Inc
10.12. Novartis Ag
10.13. Teva Pharmaceutical Industries Limited
10.14. Vectura Group Plc



List of Figures


List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: North America Pulmonary Drug Delivery Market, By Application, In 2019
Figure 6: North America Pulmonary Drug Delivery Market, By Asthma, 2019-2028 (In $ Million)
Figure 7: North America Pulmonary Drug Delivery Market, By Chronic Obstructive Pulmonary Disease, 2019-2028 (In $ Million)
Figure 8: North America Pulmonary Drug Delivery Market, By Allergic Rhinitis, 2019-2028 (In $ Million)
Figure 9: North America Pulmonary Drug Delivery Market, By Cystic Fibrosis, 2019-2028 (In $ Million)
Figure 10: North America Pulmonary Drug Delivery Market, By Other Applications, 2019-2028 (In $ Million)
Figure 11: North America Pulmonary Drug Delivery Market, By Distribution Channel, In 2019
Figure 12: North America Pulmonary Drug Delivery Market, By Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 13: North America Pulmonary Drug Delivery Market, By Retail Pharmacies, 2019-2028 (In $ Million)
Figure 14: North America Pulmonary Drug Delivery Market, By E-Commerce, 2019-2028 (In $ Million)
Figure 15: North America Pulmonary Drug Delivery Market, By End-User, In 2019
Figure 16: North America Pulmonary Drug Delivery Market, By Hospitals & Clinics, 2019-2028 (In $ Million)
Figure 17: North America Pulmonary Drug Delivery Market, By Homecare, 2019-2028 (In $ Million)
Figure 18: North America Pulmonary Drug Delivery Market, By Product, In 2019
Figure 19: North America Pulmonary Drug Delivery Market, By Metered Dose Inhalers, 2019-2028 (In $ Million)
Figure 20: North America Pulmonary Drug Delivery Market, By Dry Powder Inhalers, 2019-2028 (In $ Million)
Figure 21: North America Pulmonary Drug Delivery Market, By Nebulizer, 2019-2028 (In $ Million)
Figure 22: North America Nebulizer Market, By Pneumatic Nebulizer, 2019-2028 (In $ Million)
Figure 23: North America Nebulizer Market, By Mesh Nebulizer, 2019-2028 (In $ Million)
Figure 24: North America Nebulizer Market, By Ultrasonic Nebulizer, 2019-2028 (In $ Million)
Figure 25: North America Pulmonary Drug Delivery Market, By Accessories, 2019-2028 (In $ Million)
Figure 26: North America Pulmonary Drug Delivery Market, Country Outlook, 2019 & 2028 (In %)
Figure 27: The United States Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 28: Canada Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - PULMONARY DRUG DELIVERY
TABLE 2: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: NORTH AMERICA NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)